Facible BioDiagnostics, Inc.
New Filing
CIK: 0001910594·Biotechnology·DELAWARE·Filed: May 2, 2022
Total Offering
$2,790,000
Amount Sold
$2,790,000
Investors
18
First Sale
Feb 1, 2021
Offering Details
- Type
- Other: Simple Agreements for Future Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2019
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Steven Burden | Related Person |
| Matthew Hawkins | Related Person |
| Casi Wyatt | Related Person |
| Eric Hayden | Related Person |
| Brent Fawson | Related Person |
| Clementine Gibard Bohachek | Related Person |
| Micah Kormylo | Related Person |
Company
SEC Filing
0001910594-22-000002
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free